| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8439368 | European Journal of Cancer | 2018 | 10 Pages |
Abstract
SRT is effective and safe for oligometastatic and oligoprogressive RCC patients and may delay introduction or change of systemic therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Emmanuel Meyer, David Pasquier, Guillemette Bernadou, Gilles Calais, Pierre Maroun, Alberto Bossi, Christine Theodore, Laurence Albiges, Dinu Stefan, Renaud de Crevoisier, Christophe Hennequin, Jean-Léon Lagrange, Jean-Michel Grellard,